Toro (TTC)

NYSEIndustrialsManufacturing - Tools & AccessoriesSnapshot 2026-10-23

$105.29-0.03%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Toro’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-10-31
Revenue	—	1.1B
EPS	—	0.971
Annual ending 2026-10-31
Revenue	—	4.8B
EPS	—	4.634
Annual ending 2027-10-31
Revenue	—	4.99B
EPS	—	5.146

Management figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Full-year adjusted EPS of $4.50 to $4.62	Adjusted EPS guidance is up to $4.50-$4.62, showing strong profit growth.	Intact	Adjusted EPS falls below $4.50 in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Diluted EPS increased from $0.52 in 2025-Q1 to $0.81 in 2026-Q3 (+56%). Management raised full-year adjusted EPS guidance from $4.35-$4.50 in 2026-Q1 to $4.60-$4.65 in 2026-Q3. The trajectory shows consistent earnings growth and upward guidance revisions. Delivery assessment Oct 24, 2026
Cash from operating activities improvement	A supporting condition in Toro's published investment case. The stated target is Cash from operations >= $267M in Q2 2026.	Broken	Cash from operations falls below $200M in any quarter	Cash from operations: $182.7M FY2026-Q3; GAAP. Published target: Cash from operations >= $267M in Q2 2026. Target period is not explicitly aligned with this observation. Source published Sep 3, 2026182,700,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Jul 31, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q3. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 of last 3 quarters. Cash from operating activities was $26.1M in 2026-Q1; management highlighted robust free cash flow and working capital improvements in 2026-Q1 and Q2. The trajectory shows some progress but limited recent data for Q3. Delivery assessment Oct 24, 2026
Full-year net sales growth of 4.0% to 6.5%	A primary condition in Toro's published investment case. The stated target is 4.0% to 6.5% YoY growth.	Intact	YoY revenue growth falls below 4.0% in FY26	Revenue growth: 8.35% FY2026-Q3; GAAP. Published target: 4.0% to 6.5% YoY growth. Target period is not explicitly aligned with this observation. Source published Sep 3, 20268.353222 percent · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q3 · Period ending Jul 31, 2026 Source: company_financial_results. Reference: 88900c93-3af1-445b-b9a1-74952417b9e8. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Revenue grew from $995.0M in 2025-Q1 to $1,225.8M in 2026-Q3 (+23.3%). Management raised full-year net sales growth guidance progressively from 3%-6.5% in 2026-Q1 to 6.3%-6.6% in 2026-Q3. The trajectory is delivering consistent growth and upward guidance revisions. Delivery assessment Oct 24, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-10-31 · fmp

FY2027 EPS$5.15

Unavailable → $5.15 · observed estimates

FY2027 revenue$4.99B

Unavailable → $4.99B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	Unavailable	Unavailable	4 / 4
2026-07-25	Unavailable	Unavailable	4 / 4
2026-07-26	Unavailable	Unavailable	4 / 4
2026-07-27	Unavailable	Unavailable	4 / 4
2026-07-28	Unavailable	Unavailable	4 / 4
2026-07-29	Unavailable	Unavailable	4 / 4
2026-07-30	Unavailable	Unavailable	4 / 4
2026-07-31	Unavailable	Unavailable	4 / 4
2026-08-01	Unavailable	Unavailable	4 / 4
2026-08-02	Unavailable	Unavailable	4 / 4
2026-08-03	Unavailable	Unavailable	4 / 4
2026-08-04	Unavailable	Unavailable	4 / 4
2026-08-05	Unavailable	Unavailable	4 / 4
2026-08-06	Unavailable	Unavailable	4 / 4
2026-08-08	Unavailable	Unavailable	4 / 4
2026-08-09	Unavailable	Unavailable	4 / 4
2026-08-10	Unavailable	Unavailable	4 / 4
2026-08-12	Unavailable	Unavailable	4 / 4
2026-08-13	Unavailable	Unavailable	4 / 4
2026-08-14	Unavailable	Unavailable	4 / 4
2026-08-15	Unavailable	Unavailable	4 / 4
2026-08-16	Unavailable	Unavailable	4 / 4
2026-08-17	Unavailable	Unavailable	4 / 4
2026-08-18	Unavailable	Unavailable	4 / 4
2026-08-19	Unavailable	Unavailable	4 / 4
2026-08-20	Unavailable	Unavailable	4 / 4
2026-08-21	Unavailable	Unavailable	4 / 4
2026-08-22	Unavailable	Unavailable	4 / 4
2026-08-23	Unavailable	Unavailable	4 / 4
2026-08-24	Unavailable	Unavailable	4 / 4
2026-08-25	Unavailable	Unavailable	4 / 4
2026-08-26	Unavailable	Unavailable	4 / 4
2026-08-27	Unavailable	Unavailable	4 / 4
2026-08-28	Unavailable	Unavailable	4 / 4
2026-08-29	Unavailable	Unavailable	4 / 4
2026-08-30	Unavailable	Unavailable	4 / 4
2026-08-31	Unavailable	Unavailable	4 / 4
2026-09-01	Unavailable	Unavailable	4 / 4
2026-09-02	Unavailable	Unavailable	4 / 4
2026-09-03	Unavailable	Unavailable	4 / 4
2026-09-04	Unavailable	Unavailable	4 / 4
2026-09-05	Unavailable	Unavailable	4 / 4
2026-09-06	Unavailable	Unavailable	4 / 4
2026-09-07	Unavailable	Unavailable	4 / 4
2026-09-08	Unavailable	Unavailable	4 / 4
2026-09-09	Unavailable	Unavailable	4 / 4
2026-09-10	Unavailable	Unavailable	4 / 4
2026-09-11	Unavailable	Unavailable	4 / 4
2026-09-12	Unavailable	Unavailable	4 / 4
2026-09-13	Unavailable	Unavailable	4 / 4
2026-09-14	Unavailable	Unavailable	4 / 4
2026-09-15	Unavailable	Unavailable	4 / 4
2026-09-16	Unavailable	Unavailable	4 / 4
2026-09-17	Unavailable	Unavailable	4 / 4
2026-09-18	Unavailable	Unavailable	4 / 4
2026-09-19	Unavailable	Unavailable	4 / 4
2026-09-20	Unavailable	Unavailable	4 / 4
2026-09-21	Unavailable	Unavailable	4 / 4
2026-09-22	Unavailable	Unavailable	4 / 4
2026-09-23	Unavailable	Unavailable	4 / 4
2026-09-24	Unavailable	Unavailable	4 / 4
2026-09-25	$5.15	Unavailable	5 / 4
2026-09-26	$5.15	$4,995,840,167	5 / 5
2026-09-27	$5.15	$4,995,840,167	5 / 5
2026-09-28	$5.15	$4,995,840,167	5 / 5
2026-09-29	$5.15	$4,995,840,167	5 / 5
2026-09-30	$5.15	$4,995,840,167	5 / 5
2026-10-01	$5.15	$4,995,840,167	5 / 5
2026-10-02	$5.15	$4,995,840,167	5 / 5
2026-10-03	$5.15	$4,992,590,167	5 / 5
2026-10-04	$5.15	$4,992,590,167	5 / 5
2026-10-05	$5.15	$4,992,590,167	5 / 5
2026-10-06	$5.15	$4,992,590,167	5 / 5
2026-10-07	$5.15	$4,992,590,167	5 / 5
2026-10-08	$5.15	$4,992,590,167	5 / 5
2026-10-09	$5.15	$4,992,590,167	5 / 5
2026-10-10	$5.15	$4,992,590,167	5 / 5
2026-10-11	$5.15	$4,992,590,167	5 / 5
2026-10-12	$5.15	$4,992,590,167	5 / 5
2026-10-13	$5.15	$4,992,590,167	5 / 5
2026-10-14	$5.15	$4,992,590,167	5 / 5
2026-10-15	$5.15	$4,992,590,167	5 / 5
2026-10-16	$5.15	$4,992,590,167	5 / 5
2026-10-17	$5.15	$4,992,590,167	5 / 5
2026-10-18	$5.15	$4,992,590,167	5 / 5
2026-10-19	$5.15	$4,992,590,167	5 / 5
2026-10-20	$5.15	$4,992,590,167	5 / 5
2026-10-21	$5.15	$4,992,590,167	5 / 5
2026-10-22	$5.15	$4,992,590,167	5 / 5
2026-10-23	$5.15	$4,992,590,167	5 / 5
2026-10-24	$5.15	$4,992,590,167	5 / 5

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	2	4
2026-06-01	2	3
2026-07-01	2	3
2026-08-01	2	3
2026-09-01	3	3
2026-10-01	3	3

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 3 Buy / Strong Buy · 3 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Full-year adjusted EPS of $4.50 to $4.62Direct metric needs a verified mapping
Cash from operating activities improvementPublished status: Broken
Full-year net sales growth of 4.0% to 6.5%Revenue growth: 8.35%

Next proof point

Dec 16, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

0.9%Typical daily move · historical

Downside history

-13.9%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Toro outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

TTC is a growth-oriented industrial business, with recent financial performance in the top half of its industry. Its long-term thesis is intact, but confidence has eased from high to medium, and earnings quality is fragile.

What's priced into Toro

Valuation is described as justified, with expectations broadly aligned with the evidence and no high fragility reading. TTC trades at a modest premium to peers, so the market appears to recognize its recent strength without the evidence showing a large gap between expectations and execution.

What the fundamentals likely do

Near-term results have been strong: revenue and diluted EPS rose from 2025-Q1 to 2026-Q3, while management progressively raised full-year sales growth and adjusted EPS guidance. Tornado is contributing to sales as expected, but integration remains a watch item; recent history includes a deep miss, and industry peers have recently missed. Management changes and the industrial-sector headwind add uncertainty, though the estimated near-term miss risk is low.

What Toro hinges on

Over the next few quarters, the key test is whether TTC sustains execution and avoids reversing its recently raised guidance, which could damage management credibility. Sector signals matter too: continued strength from SNA, SWK, and RBC could support the industrial backdrop, while misses or lower guidance could weaken it.